Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

What's the Margin Trend at Endo Pharmaceuticals Holdings?
Motley Fool
Mon, 09/13/10 - 08:21 pm
Tags:
Endo, Merck, JNJ, Eli Lilly, Abbott Laboratories
Court Denies Class-Action Status in Lilly Drug Case
NY Times
Sun, 09/12/10 - 11:23 am
Tags:
Eli Lilly, Zyprexa, legal
U.S. Court of Appeals Reverses Third-Party Payor Class Certification Suit Against Lilly
Yahoo/PR NewsWire
Sat, 09/11/10 - 11:32 am
Tags:
Eli Lilly, legal
The One Thing to Know About Eli Lilly
Motley Fool
Fri, 09/10/10 - 08:13 am
Tags:
Eli Lilly, Pharma CEOs, John Lechleiter
Health-Overhaul Law Will Have ‘Moderate’ Spending Effect
WSJ Online
Thu, 09/9/10 - 11:22 am
Tags:
healthcare reform, Medicare, Eli Lilly, GSK
Lilly Invests $150 Million With Venture Firms Seeking New Drug Candidates
Bloomberg
Thu, 09/9/10 - 06:34 am
Tags:
Eli Lilly, venture capital, drug development
The 15 Highest-Yielding Pharma & Biotech Stocks
Motley Fool
Thu, 09/2/10 - 09:24 am
Tags:
PDL Biopharma, Eli Lilly, Sanofi, GSK, Bristol-Myers Squibb, AstraZeneca, Pfizer, Merck, Novartis, JNJ, Abbott Laboratories, Pharmaceutical Product Development, Techne, Biovail, Novo Nordisk
Why Anavex Is a Strong Buy
Seeking Alpha
Thu, 09/2/10 - 09:14 am
Tags:
Anavex, semagacestat, Eli Lilly, Alzheimer's disease
U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents Through March of 2014
Yahoo
Wed, 09/1/10 - 12:30 pm
Tags:
Eli Lilly, Evista, patents
After health reform, Lilly looking for more
Indianapolis Business Journal, IN
Wed, 09/1/10 - 11:44 am
Tags:
healthcare reform, Eli Lilly
5 Drugmakers With Killer Dividends
Motley Fool
Wed, 09/1/10 - 06:46 am
Tags:
dividends, Pfizer, Merck, JNJ, Eli Lilly, Bristol-Myers Squibb
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
Tags:
FDA, Questcor Pharmaceuticals, Savient, Alkermes, Arena Pharmaceuticals, Roche, Novartis, Hospira, Human Genome, Alexza, Jazz Pharmaceuticals, Biodel, Amylin, Eli Lilly, Vivus, Avanir, Cadence Pharmaceuticals, Amgen, Cumberland, Orexigen, MannKind, Bristol-Myers Squibb
Lilly wins longer halt of generic Strattera sales
Reuters
Fri, 08/27/10 - 11:32 am
Tags:
Eli Lilly, generics, Strattera, ADHD, Mylan, Teva Pharmaceuticals
Elan Defends Alzheimer’s Science
Forbes
Wed, 08/25/10 - 12:12 pm
Tags:
Elan, Alzheimer's disease, Eli Lilly
Pro Picks In Big Pharma Paying Big Dividends
Yahoo/IndieResearch
Tue, 08/24/10 - 06:07 pm
Tags:
dividends, Abbott Laboratories, Pfizer, GSK, Eli Lilly, Merck
Renegade Researcher Says Alzheimer’s Drugs From Bristol-Myers, Pfizer May Be Unsafe Or Ineffective
Forbes
Mon, 08/23/10 - 10:06 am
Tags:
Pfizer, Alzheimer's disease, Bristol-Myers Squibb, anti-amyloid, Eli Lilly
Lilly's Glimmers of Light Unlikely to Bring Future Growth
Seeking Alpha
Sun, 08/22/10 - 12:26 pm
Tags:
Eli Lilly, Cymbalta, Strattera
Eli Lilly Approaches One of Biotech's Steepest Patent Cliffs
Seeking Alpha
Sun, 08/22/10 - 12:03 pm
Tags:
Eli Lilly, Cymbalta, pain management, Zyprexa, Actos
US FDA committee recommends expanded approval for Eli Lilly's Cymbalta to a broader pain population
Pharmabiz
Sat, 08/21/10 - 01:51 pm
Tags:
Eli Lilly, Cymbalta, pain management
Analyst:Cymbalta sales won't offset Lilly's losses
Yahoo/AP
Fri, 08/20/10 - 12:47 pm
Tags:
Cymbalta, FDA, Eli Lilly, chronic pain

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.